We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Lands' End
LE
$403M
| $4.22M | ﹤0.01% |
251,426
-29,254
| -10% | -$383K |
|
|
VRS
2077
DELISTED
Verso Corporation
VRS
| $4.22M | ﹤0.01% |
233,969
+79,332
| +51% | +$1.27M |
|
2078
Heritage Financial
HFWA
$1.21B
| $4.22M | ﹤0.01% |
148,961
+347
| +0.2% | +$9.57K |
|
|
NFBK
2079
DELISTED
Northfield Bancorp
NFBK
| $4.21M | ﹤0.01% |
248,373
-3,884
| -2% | -$65.2K |
|
2080
Vishay Precision Group
VPG
$914M
| $4.21M | ﹤0.01% |
123,800
-52,713
| -30% | -$1.77M |
|
|
ARR
2081
Armour Residential REIT
ARR
$2.36B
| $4.21M | ﹤0.01% |
47,075
-585
| -1% | -$50K |
|
2082
NIO
NIO
$11.9B
| $4.2M | ﹤0.01% |
1,045,377
+64,465
| +7% | +$130K |
|
|
RAD
2083
DELISTED
Rite Aid Corporation
RAD
| $4.19M | ﹤0.01% |
270,997
+2,158
| +0.8% | +$21.1K |
|
2084
Inspire Medical Systems
INSP
$1.74B
| $4.19M | ﹤0.01% |
56,410
-1,032
| -2% | -$66.3K |
|
2085
Lloyds Banking Group
LYG
$91.3B
| $4.18M | ﹤0.01% |
1,262,661
+2,343
| +0.2% | +$7.09K |
|
2086
Resideo Technologies
REZI
$3.95B
| $4.16M | ﹤0.01% |
348,749
-175,944
| -34% | -$2M |
|
2087
Scansource
SCSC
$1.12B
| $4.13M | ﹤0.01% |
111,801
+12,123
| +12% | +$412K |
|
|
NGM
2088
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.11M | ﹤0.01% |
222,469
+198,635
| +833% | +$2.9M |
|
2089
Peapack-Gladstone Financial
PGC
$812M
| $4.11M | ﹤0.01% |
133,025
-1,576
| -1% | -$46.4K |
|
2090
LeMaitre Vascular
LMAT
$1.86B
| $4.11M | ﹤0.01% |
114,292
-6,449
| -5% | -$223K |
|
2091
Dynatrace
DT
$14.2B
| $4.11M | ﹤0.01% |
162,306
+26,125
| +19% | +$574K |
|
|
NVO
2092
Novo Nordisk
NVO
$209B
| $4.11M | ﹤0.01% |
+141,874
| New | +$3.93M |
|
2093
3D Systems Corp
DDD
$613M
| $4.09M | ﹤0.01% |
467,779
-4,169
| -0.9% | -$36.2K |
|
2094
Stratasys
SSYS
$774M
| $4.09M | ﹤0.01% |
202,340
+1,438
| +0.7% | +$28.6K |
|
2095
QuinStreet
QNST
$1.21B
| $4.09M | ﹤0.01% |
267,035
+24,429
| +10% | +$348K |
|
2096
Columbia Financial
CLBK
$1.13B
| $4.08M | ﹤0.01% |
240,885
-6,143
| -2% | -$101K |
|
|
PFNX
2097
DELISTED
Pfenex Inc.
PFNX
| $4.06M | ﹤0.01% |
369,859
+253,267
| +217% | +$2.52M |
|
|
TEN
2098
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $4.06M | ﹤0.01% |
309,865
+82,833
| +36% | +$1.09M |
|
2099
Ennis
EBF
$564M
| $4.05M | ﹤0.01% |
187,144
-35,877
| -16% | -$729K |
|
2100
Forrester Research
FORR
$224M
| $4.05M | ﹤0.01% |
97,101
+1,935
| +2% | +$72.1K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.